PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
1.030
+0.010 (0.98%)
Nov 20, 2024, 4:00 PM EST - Market closed
PAVmed Stock Forecast
PAVM's stock price has decreased by -68.5% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for PAVmed stock has a target of 21, which predicts an increase of 1,938.83% from the current stock price of 1.03.
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 10, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for PAVmed is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 1 | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $22 → $21 | Strong Buy | Maintains | $22 → $21 | +1,938.83% | Sep 10, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $8.61 | Hold | Reiterates | $8.61 | +735.92% | Aug 18, 2023 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades $25 → $9.23 | Buy → Hold | Downgrades | $25 → $9.23 | +796.12% | Jan 20, 2023 |
Lake Street | Lake Street | Strong Buy Maintains $31 → $9.23 | Strong Buy | Maintains | $31 → $9.23 | +796.12% | Jan 18, 2023 |
Lake Street | Lake Street | Strong Buy Maintains $43 → $31 | Strong Buy | Maintains | $43 → $31 | +2,885.44% | Aug 17, 2022 |
Financial Forecast
Revenue This Year
4.19M
from 2.45M
Increased by 70.80%
Revenue Next Year
16.67M
from 4.19M
Increased by 298.02%
EPS This Year
-6.00
from -9.16
EPS Next Year
-1.46
from -6.00
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 5.3M | 39.7M | 105.6M | ||
Avg | 4.2M | 16.7M | 102.6M | ||
Low | 3.0M | 1.2M | 98.6M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 114.1% | 847.7% | 533.7% | ||
Avg | 70.8% | 298.0% | 515.6% | ||
Low | 20.7% | -71.3% | 491.4% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -6.17 | -1.18 | -0.41 |
Avg | -6.00 | -1.46 | -0.40 |
Low | -5.76 | -1.71 | -0.38 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.